Clin2
NCT05496829Possibly a fitRecruiting

Improving how people take breast-cancer and heart medicines

Breast Cancer

Part of Cancer, Skin clinical trials.

This trial tests an intervention to help improve how equitably people take their prescribed breast cancer hormone therapy and heart-related prevention medicines. It may help if you have had trouble taking these medications as directed.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
350 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • Be age 18 or older
  • Have been diagnosed with stage I to III breast cancer and were prescribed hormone (endocrine) therapy
  • Be within 3 years after finishing early active breast cancer treatment (like surgery, chemo, or radiation; not counting HER2-targeted therapy)
  • Be taking at least one medicine for heart protection, such as a blood pressure medicine (antihypertensive) or a cholesterol medicine (statin)
  • Tell the study you sometimes do not take your breast cancer hormone medicine and/or your heart prevention medicine as you should
  • No signs that your breast cancer has come back (no recurrence)
  • Be able to participate in study tasks, understand the study, and give consent; you must speak English or Spanish
  • Get your care at NewYork-Presbyterian through their system with a primary care doctor or cardiologist listed

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06121453Recruiting
Adherence support for metastatic breast cancer patients

This study tests a program to help people with metastatic breast cancer take their endocrine therapy, CDK4/6 inhibitors, and heart-related medications as prescribed. If you sometimes miss doses of these medicines, you may be able to join.

New York, New York
NCT06726889Recruiting
Improving oral medication adherence in metastatic breast cancer

This study tests a program to help people with metastatic breast cancer take their oral medications as prescribed. It uses a smartphone app to track and support medication adherence, which may improve treatment outcomes.

Milan
NCT06781996Recruiting· Phase 3
Digital tool to help manage hormone therapy side effects

This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.

Villejuif
NCT03245411Recruiting
Helps cancer patients take oral medicines as prescribed

This study tests a set of practical support steps to help people with advanced cancer take their oral (by mouth) treatment medicines correctly. It may help improve adherence and reduce missed doses or appointments.

Philadelphia, Pennsylvania
NCT06543394Enrolling by invitation
Helping patients take blood pressure medication regularly

This trial tests whether a behavioral science approach can help people with high blood pressure take their medication as prescribed. If you have trouble remembering or sticking with your blood pressure pills, this study may help you find better ways to stay on track.

New York, New York
NCT06834204Enrolling by invitation
Better care coordination for cancer survivors

This study tests a program to improve communication between your cancer team and your regular doctor. If you have heart or diabetes risks and you're being treated for breast, prostate, bladder, or endometrial cancer, this trial may help coordinate your care.

New Brunswick, New Jersey

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.